277 related articles for article (PubMed ID: 27836865)
1. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
Yoshimi A; Abdel-Wahab O
Clin Cancer Res; 2017 Jan; 23(2):336-341. PubMed ID: 27836865
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
3. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies.
Taylor J; Lee SC
Genes Chromosomes Cancer; 2019 Dec; 58(12):889-902. PubMed ID: 31334570
[TBL] [Abstract][Full Text] [Related]
4. [RNA splicing dysregulation in hematological malignancies].
Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A
Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725
[TBL] [Abstract][Full Text] [Related]
5. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
6. Spliceosomal factor mutations and mis-splicing in MDS.
Hershberger CE; Daniels NJ; Padgett RA
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101199. PubMed ID: 33038983
[TBL] [Abstract][Full Text] [Related]
7. Aberrant RNA splicing and therapeutic opportunities in cancers.
Yamauchi H; Nishimura K; Yoshimi A
Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of spliceosomal assembly.
Chiou NT; Lynch KW
Methods Mol Biol; 2014; 1126():35-43. PubMed ID: 24549654
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into precursor messenger RNA splicing by the spliceosome.
Shi Y
Nat Rev Mol Cell Biol; 2017 Nov; 18(11):655-670. PubMed ID: 28951565
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of spliceosome in cancer and immunity.
Yang H; Beutler B; Zhang D
Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of RNA Splicing in Cancer.
Bonner EA; Lee SC
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283
[TBL] [Abstract][Full Text] [Related]
12. Models of spliceosomal intron proliferation in the face of widespread ectopic expression.
Rodríguez-Trelles F; Tarrío R; Ayala FJ
Gene; 2006 Feb; 366(2):201-8. PubMed ID: 16288838
[TBL] [Abstract][Full Text] [Related]
13. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.
Seiler M; Yoshimi A; Darman R; Chan B; Keaney G; Thomas M; Agrawal AA; Caleb B; Csibi A; Sean E; Fekkes P; Karr C; Klimek V; Lai G; Lee L; Kumar P; Lee SC; Liu X; Mackenzie C; Meeske C; Mizui Y; Padron E; Park E; Pazolli E; Peng S; Prajapati S; Taylor J; Teng T; Wang J; Warmuth M; Yao H; Yu L; Zhu P; Abdel-Wahab O; Smith PG; Buonamici S
Nat Med; 2018 May; 24(4):497-504. PubMed ID: 29457796
[TBL] [Abstract][Full Text] [Related]
14. Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis.
Inoue D; Bradley RK; Abdel-Wahab O
Genes Dev; 2016 May; 30(9):989-1001. PubMed ID: 27151974
[TBL] [Abstract][Full Text] [Related]
15. Non-canonical functions of spliceosome components in cancer progression.
Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO
Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
17. Modulating splicing with small molecular inhibitors of the spliceosome.
Effenberger KA; Urabe VK; Jurica MS
Wiley Interdiscip Rev RNA; 2017 Mar; 8(2):. PubMed ID: 27440103
[TBL] [Abstract][Full Text] [Related]
18. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
19. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract][Full Text] [Related]
20. Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations.
Pangallo J; Kiladjian JJ; Cassinat B; Renneville A; Taylor J; Polaski JT; North K; Abdel-Wahab O; Bradley RK
Blood; 2020 Mar; 135(13):1032-1043. PubMed ID: 31961934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]